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Background: No standard protocols are available for cognitive rehabilitation (CR) in
conditions like Major or Mild Neurocognitive disorder (M-NCD or m-NCD, respectively);
however, preliminary data seem to indicate that such interventions might have cost-
effective beneficial effects and are free from side effect or adverse events. Three basic
approaches are known: cognitive stimulation (CS), cognitive training (CT), and CR.
Objective: Aim of this study was to assess the efficacy of a protocol of group intensive
cognitive activation (g-ICA) in patients with both M-NCD and m-NCD; the protocol was
specifically arranged in our Research Institute, based on the principles of the central role
of the patient and the mediation pedagogy.
Subjects and Methods: Sixteen patients with M-NCD and fifteen patients with m-NCD
were enrolled, as well as eleven patients with M-NCD who were used as a control group
(CG). The intervention was carried-out by a clinical neuropsychologist with daily group
sessions over a period of 2 months. Neuropsychological assessment was performed at
baseline and after the completion of the rehabilitative intervention.
Results: General cognitive functioning, attention, ideomotor praxis and visual memory
scores were found to be significantly increased in all patients. Beneficial and significant
effects were also found for constructive praxis in M-NCD and for executive functioning
in m-NCD. All areas of the language function were significantly ameliorated in m-NCD,
while this happened only for verbal repetition and syntax-grammar comprehension in
M-NCD. No changes were detected for long- and short-term verbal memory, which
were found to be worsened in controls without activation.
Conclusion: Our findings seem to indicate that g-ICA might be effective in inducing
beneficial changes on the general cognitive functioning and other specific functions in
patients with both m-NCD and M-NCD. Moreover, the specific protocol proposed, even
if susceptible of important improvement, is easy to carry out within hospital facilities and
cost-effective.
Keywords: cognitive stimulation, cognitive training, dementia, mild cognitive impairment, patient-focused
cognitive intervention
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INTRODUCTION
The Statistical Manual of Mental Disorders—fifth edition
(DSM-5; American Psychiatric Association, 2013) provides
the new cluster of neurocognitive disorders which includes
three syndromes: delirium, mild, and major neurocognitive
disorders (m-NCD and M-NCD respectively). M-NCD is
largely synonymous with dementia, although the criteria have
been modified so that impairments in memory or learning
are not essential for the diagnosis, except for NCD due to
Alzheimer’s disease (AD). M-NCD is characterized by the
evidence of significant acquired deficits in one or more cognitive
domains, based on concerns reported by the individual or
the informants and preferably documented by standardized
neuropsychological testing or quantified clinical assessment;
such deficits must interfere with independence in everyday
activities. m-NCD is synonym for mild cognitive impairment
(MCI) and is characterized by a mild acquired cognitive
decline not interfering with independence in everyday activities,
even though greater effort or compensatory strategies may
be required. The reason for diagnosing m-NCD resides in
the increasing interest in early diagnosis and intervention
to prevent or postpone dementia, although m-NCD is
not always a precursor of dementia (Langa and Levine,
2014).
The DSM-5 also describes criteria for the diagnosis of specific
etiological subtypes of both NCDM-NCD and m-NCD, based on
their clinical features and biomarkers (e.g., Frontotemporal lobar
degeneration, Traumatic Brain Injury, AD, Vascular Disease,
Lewi body Disease, and Parkinson’s Disease), and consistent
with those developed by various expert groups. Nevertheless,
establishing the etiology in m-NCD is rather difficult and
may remain unspecified in many patients. For some etiologies,
the level of certainty is also well defined, with ‘‘probable’’
representing a higher level of certainty than ‘‘possible’’ (for a
review of NCD, see Sachdev et al., 2014).
Options for treating M-NCD include both pharmacological
and non-pharmacological therapies. At present, no drugs capable
of modifying the disease and totally control the symptoms
are available (Hildreth and Church, 2015); therefore, cognitive
interventions have been gradually and increasingly focused as
an emerging therapeutic approach which could aid prevention
and treatment of dementia, especially combined with exercise
and pharmacological therapy (Loewenstein et al., 2004; Law
et al., 2014). The hypothesis that persons with neurocognitive
diseases might benefit from cognition-based intervention derives
from the concepts of neuronal plasticity and cognitive reserve
and from a general view that the lack of cognitive activity
hastens cognitive decline, in normal ageing individuals as well
as those with dementia. However, according with some studies,
deterioration cannot be stopped after 2 years of treatment in
patients with dementia (Requena et al., 2006; Woods et al.,
2012). Another study by Jedrziewski et al. (2014) carried out with
community-resident and institutionalized persons, showed that
engagement in cognitive activities was inversely associated with
the onset of cognitive impairment at 5-year follow-up, but was no
longer significant at 10-year follow-up, this resulting in the fact
that cognitive interventions possibly lower the risk for cognitive
impairments and dementia and might delay their onset.
Neural plasticity can be defined as the ability of the nervous
system to adapt its structural organization in response to
factors affecting its integrity and functioning. Protecting neural
plasticity in brain regions typically affected in ADmight improve
the neurological functioning and prevent the loss of neuronal
processes that occur in this disease (Buschert et al., 2010). Neural
plasticity also plays a role in cognitive reserve which represents
the brain’s ability to make flexible and efficient use of cognitive
networks when performing tasks in the presence of brain
pathology (Stern, 2002). Persons with higher cognitive reserve
tend to have better clinical outcomes for any level of pathology
and brain reserve (Stern, 2013). Among all the factors influencing
cognitive reserve, mentally stimulating activities were shown
to have the largest effect on the risk for dementia and might
attenuate cognitive decline. Therefore, cognitive interventions
could potentially delay the onset of dementia, as in the case
of m-NCD, attenuate the clinical symptoms associated with
M-NCD and partially reduce the speed of decline (Buschert et al.,
2010). As compared with pharmacological treatment, cognitive
intervention appears to be less expensive and more cost-effective
(Buschert et al., 2010) and free from side effects or adverse events.
However, research in this area is rather scarce and evidence of
effectiveness rather controversial (Alves et al., 2013); moreover,
to date, no standard protocols are available for cognitive
intervention in conditions such as M-NCD or m-NCD. Three
main cognition-based approaches emerge from the literature:
cognitive stimulation (CS), cognitive training (CT) and cognitive
rehabilitation (CR; Clare and Woods, 2004; Buschert et al., 2010;
Alves et al., 2013; Choi and Twamley, 2013).
CS includes a range of group activities with the aim to enhance
general cognition and social functioning. This approach assumes
that cognitive functions work together and should be stimulated
at the same time in a social setting. CS is based on reality
orientation (RO), first described (Taulbee and Folsom, 1966) as
a technique to improve the quality of life of confused elderly
people, although its origins lie in an attempt to rehabilitate
severely disturbed war veterans. RO involves the presentation
of orientation and memory information, relating, for example,
to time, place, and person, in order to provide the person
with a greater understanding of his/her surroundings, possibly
resulting in an improved sense of control and self-esteem.
The basic principles of RO have been incorporated in the
everyday clinical practice and in new formats of treatments.
Of notice, the cognitive stimulation therapy (CST), by Spector
et al. (2003), a brief group intervention (14 person-centered
sessions of themed enjoyable activities), designed for patients
with dementia, has received evidence of its efficacy on cognitive
functions and quality of life (Woods et al., 2012). CST seem to
be independent of whether people are taking acetylcholinesterase
inhibitor (AChEI) medication, and that being older or female
implies increased cognitive benefits from the intervention; care
home residents improve more than community residents on
quality of life, but the community sample seems to improve
more in relation to behavior problems. This method has been
published as a manual (Spector et al., 2006) and is the only non-
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pharmacological intervention recommended by the National
Institute for Health and Clinical Excellence (2007) for the
treatment of cognitive symptoms in dementia. It also appears to
be cost-effective (Knapp et al., 2006).
CT is an approach consisting of computer-based or paper-
and-pencil cognitive exercises with different levels of difficulty,
targeting specific cognitive functions (e.g., attention, memory,
problem-solving). It is performed individually or in group, with
the aim to enhance targeted functions and teach compensatory
techniques, generalizable to daily life. There is evidence, in pre-
dementia and mild-to-moderate AD, of cognitive improvements
(Cipriani et al., 2006; Talassi et al., 2007), but not of
generalization (see Alves et al., 2013). CT is especially employed
with MCI patients, mainly focusing on episodic memory,
but also on attention, executive functions, language, visual-
spatial abilities and processing speed (Simon et al., 2012).
Computerized CT did not show higher improvements when
compared to non-computerized training. CT also includes
restorative (such as errorless learning, spaced retrieval, errorful
learning, reminiscence therapy) and compensatory strategy (such
as visual imagery, method of loci, mind mapping, cueing,
external memory aids), frequently applied simultaneously. The
results from different studies are rather inconsistent with regard
to the enhancement of memory domain and generalization to
other cognitive functions (Simon et al., 2012). A recent meta-
analysis of randomized controlled trials by Wang et al. (2014)
found significant effects on global cognitive functions, and weak
evidence of improvements in executive functions and delayed
memory. Very briefly, CST appears to be more effective in
patients with dementia (Yuill and Hollis, 2011), whereas CT
seems to be more effective in patients with MCI (Buschert et al.,
2010).
CR is an individualized approach, which employs any
intervention strategies that might enable patients and their
families to manage cognitive deficits, considered within the
interaction between the patient and the environment. The
main difference between this approach and the CT is the full
involvement of the family in the treatment. Compensatory
methods, verbal instructions and physical demonstrations are
used (Choi and Twamley, 2013). To date, there are very few
studies about this approach and evidence of CR benefits is still
to be obtained (Alves et al., 2013).
Other non-pharmacological multicomponent approaches are
described in the literature that substantially appear to be
variations of CT, for example interventions combining CT with
RO (Raggi et al., 2007), with physical exercises and CS (Olazarán
et al., 2004), with activities of daily living (ADL; Avila et al.,
2004), or with transcranial magnetic stimulation (Bentwich et al.,
2011). Some authors (Yamaguchi et al., 2010; Yamagami et al.,
2012), shifting from ‘‘what’’ is taken to ‘‘how’’ it is taken,
suggested a combined treatment, that is the brain-activating
rehabilitation (BAR), based on five principles: enjoyable activities
in an accepting atmosphere, empathetic communication between
patients as well as between the therapist and the patients,
enhancing motivation by means of praises, conferring a social
role to each patient (based on his/her remaining abilities),
errorless learning in order to maintain the patient’s dignity;
evidence of a decreased social withdrawal and global severity
of dementia was provided by a randomized clinical trial but no
difference was found in cognitive tests.
In summary, taken as a whole, previous studies show
evidence for small but consistent effects of non-pharmacological
cognitive interventions in improving global cognitive functions
in patients with both MCI or dementia, especially AD. At
present, however, no standardized intervention programs have
been designed yet and research in this field ‘‘is still in its
infancy, and in spite of the growing evidence of its effectiveness,
is still lacking recognition among health professionals as well
as caregivers’’ (Alves et al., 2013). Therefore, the search for
additional evidence concerning the efficacy of these approaches
for each type of dementia and deterioration stages is strongly
recommended. Considering that the worldwide number of
patients with dementia is expected to dramatically increase,
the need to implement cognitive interventions in inpatient and
outpatient services for subjects with NCD has become more and
more compelling.
The aim of this article is to report preliminary results on
the implementation of the group intensive cognitive activation
(g-ICA), a combined treatment properly designed in our
Research Institute, and delivered in an inpatient hospital setting
to persons with M-NCD and m-NCD, on the basis of their
cognitive outcomes. This approach represents a proposal aimed
at the enrichment of the traditional rehabilitation programs
provided in hospitals, generally based on physical and language
therapy.
MATERIALS AND METHODS
Participants
The patient group included 16 subjects (6 males and 10
females) with mild-to-moderate M-NCD and 15 patients with
m-NCD (7 males and 8 females), diagnosed on the basis of
the DSM-5 criteria by a multidisciplinary team (including a
senior geriatrician, a neurologist, and a psychologist) before their
admission at the Rehabilitation Unit of our Institute. As far as
the M-NCD sample is concerned, in seven patients the disease
was due to possible AD, in three to vascular disease, in three
to frontotemporal lobar degeneration-language variant, in one
to frontotemporal lobar degeneration-behavioral variant, and in
one to traumatic brain injury. Patients with M-NCD due to
possible AD were treated with cholinesterase inhibitors soon
after the completion of the diagnostic process. Within the m-
NCD sample, in six patients the disease was due to possible
AD, in five to vascular disease, in two to traumatic brain injury
and in two to another medical condition (namely removal of
benign brain tumors). Mean chronological age of patients with
M-NCD was 64 years (±10.64 SD); early onset of the diseases
(<65 years) was evident in 11 individuals. Mean chronological
age of patients with m-NCD was 57 years (±9.82 SD). Patients
with M-NCD were assigned to treatment groups on the basis
of the severity of the disorder (mild or moderate) following the
waiting list; patients with m-NCD were assigned to treatment
groups following the waiting list.
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Inclusion criteria to be met for M-NCD were as follows:
(a) DSM-5 diagnostic criteria for M-NCD; (b) score between
10 and 23 at the mini mental state examination (MMSE; Folstein
et al., 1975); (c) score between 40 and 85 (mild or moderate
cognitive decline) at the milan overall dementia assessment
(MODA; Brazzelli et al., 1994); (d) score between 1 and 2 at
the clinical dementia rating (CDR; Hughes et al., 1982); (e) loss
of almost one ADL (Katz et al., 1970) and/or instrumental
activities of daily living (IADL; Lawton and Brody, 1969); and
(f) patients presented with some communication abilities, no
major sensorial (sight and hearing) or physical illnesses and
no behavioral problems impairing their participation to group
activities. Inclusion criteria to bemet for m-NCDwere as follows:
(a) DSM-5 diagnostic criteria for m-NCD; (b) score between
24 and 26 at theMMSE; (c) score between 85.5 and 89 (borderline
cognitive level) at the MODA; (d) score 0.5 at CDR; (e) ADL
and IADL globally maintained; and (f) patients had no major
sensorial (sight and hearing) or physical illnesses impairing their
participation to group activities.
A control group (CG) was also recruited which included
11 elderly with M-NCD (2 males and 9 females) who received
daily care and assistance, with daily animation activities and
weekly attendance of religious events. Their mean age was
69 years (±7.87 SD). Inclusion criteria were: (a) score between
10 and 23 at the MMSE (Folstein et al., 1975); (b) score between
40 and 85 (mild or moderate cognitive decline) at the MODA
(Brazzelli et al., 1994); (c) score between 1 and 2 at the CDR
(Hughes et al., 1982); and (d) loss of almost one ADL (Katz et al.,
1970) and/or IADL (Lawton and Brody, 1969).
Procedures
g-ICA is an intensive combined group treatment including
30 cognitive activation sessions, delivered by a trained clinical
neuropsychologist, supported by a practicing psychologist.
A pre/post neuropsychological assessment was administered to
all groups of patients.
Also for CG, two neuropsychological battery administrations
were carried out, the last after 2 months from the first. CG did
not benefit from the g-ICA program.
The neuropsychological battery and the arrangement of
sessions and contents are described in the following paragraph.
Neuropsychological Instruments
In order to overcome the weaknesses typically deriving from only
one or two measures of the global cognitive functioning and
with the aim of obtaining a wide-spectrum neuropsychological
profile, a comprehensive neuropsychological battery was used,
as suggested by Bianchi and Dai Prà (2008). Global cognitive
functioning was evaluated by means of a number of measures,
and namely the MMSE (Folstein et al., 1975), the MODA
(Brazzelli et al., 1994), and the montreal cognitive assessment
(MoCA, Nasreddine et al., 2005); to assess reasoning ability and
intellectual level, the colored progressives matrices (CPM; Basso
et al., 1987) were used; short termmemory was assessed bymeans
of the Digit Span (Orsini et al., 1987), the Serial repetition of
two-syllable words (Spinnler and Tognoni, 1987), and test of
Corsi (Orsini et al., 1987); verbal episodic memory (immediate
and delayed recall) was investigated by means of the Rey’s 15
words (Carlesimo et al., 1996); non-verbal episodic memory by
the Enhanced Cued Recall (Grober et al., 1988) and the Rey’s
Complex Figure-memory reproduction (Carlesimo et al., 2002);
selective attention was evaluated using the Digit Cancellation
test (Spinnler and Tognoni, 1987); for the spatial cognition
and constructional apraxia the copy of Rey’s Complex Figure
(Caffarra et al., 2002) was used; ideomotor praxis was assessed
by means of the Imitating Gestures Test (De Renzi et al., 1980);
for the assessment of the language abilities, the Aachener Aphasia
Test (Italian version) was employed (Luzzatti et al., 1996) and
for the frontal functions, the frontal assessment battery (FAB;
Dubois et al., 2000).
The g-ICA Protocol
The g-ICA protocol is based on two general principles:
the central role of the patient and the mediation pedagogy.
The patient-centered principle consists in taking into account
the patients’ needs and expectations. Patients with dementia are
commonly willing to improve their health condition, maintain
their cognitive and daily-living abilities while minimizing any
memory loss; moreover, they need to be listened to, and
receive emotional support (Bossen et al., 2009). Consequently,
g-ICA was properly designed to include activities tapping
on a wide spectrum of cognitive abilities, which appeal to
the cognitive strength of patients, bringing them out of a
vicious circle of failure toward a new virtuous circle based
on capabilities and abilities. The principle of the mediation
pedagogy comes from the theory of Structural Cognitive
Modifiability which is, in practice, the mediated learning
experience (Feuerstein, 1999). In our approach, mediation
is focused on interpersonal relationships, characterized by
a loop of dynamic and positive feedbacks between patients
and the mediator; this latter, in a respectful and pleasant
atmosphere, essentially encourages the patients—never standing
in for them—to engage with stimuli and provides the required
prompts, so they can actively and successfully complete the
task. The mediator is required to show empathy, sense of
humor and the ability to make cognitive activities as pleasant
as possible. A package of proactive (antecedent) and reactive
(consequent) procedures (Cooper et al., 2007) is used, in order
to raise the patients’ motivation in the working area and
during cognitive activities, and maintain self-esteem; namely:
a prosthetic physical environment, made of a separate and
comfortable room, equipped with a calendar, a wall clock and
other visual cues, a computer, a video projector and a whiteboard;
a 20 min break with a snack; errorless learning (prompts,
prompt-fading and delayed prompt); variation of activities and
materials; variation of task difficulties; use of social positive
reinforcements; correction of errors, by highlighting positive
aspects of the response and adding new stimuli aimed to lead
patients to independently overview the global quality of their
response.
The g-ICA is an intensive group treatment combining CS
(including RO) and CT; in our setting, each group was made
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TABLE 1 | Weekly plan of activities in g-ICA.
Day Cognitive
functions
stimulated
Activities examples for participants
with M-NCD
Activities examples for participants
with m-NCD
Every day Global Reality orientation (day, month, year, season, weather, time
estimate, name of participants, building one’s own identity
card and other personal information, temporal and spatial
relations)
Reality orientation (date; mental calculations-hours and days
within a month, a season or a year)
Ecological memory Memory in the boxes: group game with personal objects; this
game was taken from Florenzano (1988) and then adapted
Memory in the boxes (group game with neutral objects)
Monday/Thursday Ideomotor praxis Each participant, in turn, moves a part of his/her body
(right or left); the other participants have to imitate the
movement (right and left, accordingly); variations can include
different number of repetitions and imitation of two series of
movements
Each participant, in turn, moves a part of his/her body (right
or left); the other participants have to imitate the movement
(right and left, accordingly); variations can include imitation of
three or more series of movements forward and backward
Monday/Friday Global Getting pairs of cards (it is a group card game; each set
contains paired cards on established themes—such as food,
objects, clothes, etc.; each participant receives 6–8 cards
and is required to reconstruct the highest number of pairs
following certain rules)
Getting pairs of cards (in this case, cards have to be paired
not only on the basis of their sameness, but also on the basis
of logical matching; each player can receive up to 20 cards)
Visual, auditory and
spatial memory
Little computerized and non-computerized memory games
for adults (shapes, cards, black and white figures, flags,
faces, colors, numbers, letters, smiles, word retrieval,
sentences repetition, location of objects, etc.)
Big computerized and non-computerized memory games for
adults
Tuesday/Thursday Auditory and visual
selective attention
Computerized and non-computerized non-verbal
cancelation tasks/sounds and words recognition (one or two
meaningful target stimuli)
Computerized and non-computerized non-verbal
cancelation tasks/sounds and words recognition (two or
more meaningful or non-meaningful target stimuli)
Global Functional tasks (telling time, counting money, using a
calendar, reading simple instructions, using the mobile
phone, etc.)
Functional tasks (solving daily math problems,
understanding medicine labels, writing a phone message,
using the internet, etc.)
Tuesday/Friday Verbal language Naming (objects, pictures, features, functions, classes);
pictures description; sentences repetition; reading,
comprehension, reconstruction of a brief story through
pictures and written sentences; creating a story II (guided
group play)
Sentences repetition; verbal fluency; verbal inference;
creating a story I (each participant adds a new sentence at a
time, keeping a logic sequence of the story events); creating
a story II (guided work play).
Wednesday Constructional
praxis
Drawing tasks (figure copy or completion ); easy tangrams;
cubes or matches constructions
Tangrams; identify and outline given figures within a cloud
of dots; differentiating (divide a whole into its parts) and
integrating (join parts into a whole); computerized and non
computerized stencil design (through superimposed parts).
Semantic memory Starting from a central topic, all related information were retrieved by using a fixed diagram including category,
environment, features, functions and free associations (Celentano et al., 2002)
Ecological problem
solving
Starting from a visual presentation of a everyday problem
situation, participants are required to express what they think
about the situation and what they would do (tasks adapted
from Schwartz, 1990, 1993).
Starting from a verbal presentation of a everyday problem
situation, participants are required to analyze the situation,
hypothesize the antecedents and the purposes of the
characters, and finally to express what they think about the
situation and what they would do
of four/five participants. Interventions were delivered in an
inpatient hospital setting, with daily group sessions, each lasting
approximately 3.5 h, 5 days a week (from Monday to Friday),
over a period of 2 months. During the first and the last weeks,
neuropsychological assessments were administered; cognitive
activation sessions extended over a period of 6 weeks. Each
session begun with the mediator welcoming the patients, then
engaging in a little discussion about gossip/crime news recently
happened or about facts that had taken place where patients
resided; then, a short overview of the activities carried out
in the last meeting was discussed and a RO activity (day,
month, year, season, weather, time, name of participants) was
started, followed by cognitive or non-cognitive tasks, a short
break, and cognitive or non-cognitive tasks once again; finally,
the overall course of the session and the level of engagement and
feelings of patients were discussed. Contents were organized on
a weekly basis, in order to stimulate a wide range of cognitive
functions; the level of difficulty of the activities was adapted to
the group cognitive capability (Table 1). Both paper-pencil and
computer activities were employed to train specific cognitive
functions.
Statistical Analysis
We first obtained descriptive statistics for all parameters
measured in this study which served to calculate the Cohen’s d
value. Cohen’s d is defined as the difference between two means
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divided by the pooled standard deviation for those means.
According to Cohen, 0.2 is indicative of a small effect, 0.5 of a
medium and 0.8 of a large effect size.
Most variables analyzed in this study did not show a normal
distribution; for this reason, non-parametric statistics were
subsequently used. Thus, the results obtained from the pre-
and post-treatment assessments in both groups of patients and
in both M-NCD subgroups were compared by means of the
Wilcoxon test for paired data sets. Significance level was set
as p < 0.05. However, as for each parameter four different
comparisons were performed, also the Bonferroni correction was
applied and the corresponding corrected significance level was
set at p< 0.0125.
The comparison between the results of the first and second
neuropsychological battery administration in the CG was carried
out by means of the Wilcoxon test for paired data sets.
The comparison between the M-NCD group and controls
was carried out by means of the Mann-Whitney U test. The
significance level was set as p< 0.05.
Ethics Approval
This study was carried out in accordance with the
Regulations of the Local Ethics Committee ‘‘Oasi Maria SS.’’
(CE17/06/2013OASI) abiding by the National Regulations for
Ethics Committees. Written informed consent was obtained by
all volunteering subjects before entering the study, in accordance
with the Declaration of Helsinki. The population involved in
this study, albeit vulnerable, were able to personally give their
consent to participate to the study. In case of patients with
dementia, caregivers have been also informed about objectives
and procedures of the research study.
RESULTS
Table 2 reports descriptive statistics and effect size of the results
obtained in all groups of patients. The statistical significance of
the difference between the results obtained from pre- and post-
treatment assessments are reported in Table 3; the findings in
m-NCD and M-NCD will be described separately.
Patients with M-NCD
Global cognition improved significantly, as indicated by
the MODA and MMSE, in the whole sample as well
as in both subgroups with and without AD. The whole
sample and the group with M-NCD due to AD showed a
statistically significant improvement also at the MoCA. When
analyzing the sub-sessions of MODA, namely Orientations and
Neuropsychological Tests, it must be noticed that all the groups
improved in neuropsychological performance (M-NCD total
sample: p = 0.017; M-NCD due to AD: p = 0.018; M-NCD non-
AD: p = 0.025), whereas Orientations turned out to be improved
in non-ADM-NCD only (p = 0.008).
No difference was found between pre- and post-treatment
comparisons for reasoning ability, frontal functions and memory
tests, except for the non-verbal Enhanced Cued Recall, in which a
statistically significant difference was found in the whole sample
(with a small Cohen’s d) and in the M-NCD due to AD. Selective
attention improved in the whole sample, whereas in the two sub-
groups with and without AD changes did not reach statistical
significance.
Statistically significant differences were found for
language abilities in the whole sample; namely, for syntactic
comprehension of sentences (Token test; with a small Cohen’s d)
and verbal repetition (but small Cohen’s d); in the sub-group
withM-NCD due to AD, for syntactic comprehension, ecological
comprehension (with a small Cohen’s d) and naming; and in the
sub-group with M-NCD non-AD, for verbal repetition only.
Enhanced ideomotor praxis (Imitating Gestures test) was
found in all the groups, whereas constructional praxis (Rey’s
Complex figure-copy) reached a statistical significance in the
whole sample and in the M-NCD due to AD.
In summary, following the g-ICA treatment, patients with
M-NCD, both the whole sample and the two sub-groups with
and without AD, showed improvements in global cognitive
function and ideomotor praxis. The sub-group with M-NCD
due to AD showed improvements also in some verbal language
domains, such as verbal comprehension and naming, in
constructional praxis and delayed visual memory. The sub-
group with M-NCD non-AD showed improvements in verbal
repetition and orientations. Reasoning abilities, verbal memory
and executive functions did not appear to be susceptible of
improvements.
Patients with m-NCD
Patients with m-NCD showed statistically significant
improvements in global cognitive functioning, reasoning,
executive function, short termmemory (digit span), delayed non-
verbal memory (Rey’s complex figure-memory reproduction),
selective attention, ideomotor praxis, and in all language
domains (namely, syntactic and ecological verbal comprehension
of sentences, naming, written language), except for repetition.
Comparison between M-NCD and CG
The comparison between M-NCD and CG basically confirmed
the results obtained from the comparison between the pre- and
post-treatment assessments in patients with M-NCD (Table 4).
In fact, significant differences were found in the general
cognitive functioning, in visual memory, selective attention,
praxis, and in some language areas (syntactic verbal
comprehension and repetition). Significant differences were
obtained also in the visual-spatial reasoning (CPM), immediate
verbal recall, frontal functions, naming, and written language.
DISCUSSION
The g-ICA is a short (6 weeks) combined intensive intervention
based on mediation pedagogy and patient-centered principles.
It is characterized by CS activities and cognitive tasks. Other
multi-component approaches have been described in the
literature (Avila et al., 2004; Olazarán et al., 2004, 2010; Sitzer
et al., 2006; Raggi et al., 2007), usually implemented in patients
with dementia. In our study, the combined treatment has also
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TABLE 3 | Statistical significance of the differences between the results
obtained from pre- and post-treatment evaluations in patients with
m-NCD and M-NCD (Wilcoxon test).
M-NCD M-NCD due to M-NCD not m-NCD
all possible AD due to AD
(n = 16) (n = 7) (n = 9) (n = 15)
p p p p
Global cognitive function
MODA 0.005∗ 0.018 0.008∗ 0.015
MMSE 0.008∗ 0.018 0.028 ns
MoCA 0.021 0.043 ns 0.008∗
Reasoning and cognitive level
Colored progressive
matrices ns ns ns 0.024
Memory
Digit span ns ns ns ns
Corsi’s test ns ns ns ns
Serial repetition of
two-syllabic words ns ns ns 0.022
Rey’s 15 words-immediate recall ns ns ns ns
Rey’s 15 words-delayed recall ns ns ns ns
Rey’s complex figure-
memory reproduction ns ns ns 0.007∗
Enhanced cued recall 0.041 0.028 ns ns
Selective attention
Digit cancellation test 0.048 ns ns 0.008
Praxis
Imitating gestures test 0.002∗ 0.018 0.043 0.001∗
Rey’s complex
figure-copy 0.044 0.043 ns ns
Frontal functions
Frontal assessment battery ns ns ns 0.002
Language
Aachener aphasia test
(AAT)—Token test 0.006∗ 0.028 ns 0.019
AAT—Repetition 0.009∗ ns 0.028 ns
AAT—Written language ns ns ns 0.035
AAT—Naming ns 0.043 ns 0.018
AAT—Comprehension ns 0.043 ns 0.018
∗Significant after Bonferroni correction.
been implemented with m-NCD, due to the program flexibility
and to customable tasks; furthermore, unlike other studies in
the literature, in which results are usually described for AD or
for patients with unspecified types of dementia (for a review see
Alves et al., 2013), in our study results were also analyzed in the
two sub-groups, with and without AD.
The whole M-NCD showed statistically significant
improvements in almost all the investigated domains after
treatment and most of these improvements were significantly
higher than the changes observed in the CG in which worsening
was the rule. As far as the global cognition is concerned,
improvements were evident for the whole group with M-NCD
and for both sub-groups (with and without AD); these positive
modifications were found in all the global cognitive functioning
batteries used, namely MoCA, MMSE and MODA, although
p values were greater for MODA and MMSE than for MoCA:
differences between p values might be ascribed to the fact
that MoCA trials are more difficult than those included
in the other two cognitive batteries, since MoCA enables
to detect also a mild cognitive decline. These results are
congruent with those from the literature, with regard to CS
(Sitzer et al., 2006; Woods et al., 2012; Aguirre et al., 2013;
Alves et al., 2013) and CT programs (Cipriani et al., 2006;
Sitzer et al., 2006; Talassi et al., 2007; Alves et al., 2013), as
well as to integrated programs (Olazarán et al., 2004). Our
study also provides additional information about the global
cognitive gains in patients with non-AD M-NCD. Moreover,
the improved global cognition, indeed, seems to be more related
to improvement in neuropsychological functioning and less
to orientation for which, however, only patients with non-
AD M-NCD showed a statistically significant improvement.
These data might be explained by to the fact that orientation
requires the use of memory, the cognitive function which first
deteriorates in AD, in conjunction with attention and executive
functioning (Traykov et al., 2007), and appears less susceptible
of improvements following CS or training. In addition, from
our study information about reasoning abilities and IQ—which
were not improved—can also be derived: therefore, it can be
hypothesized that improvements in global cognitive functioning
are not related to increased IQ or reasoning abilities, but rather
to more efficient cognitive functions as a whole. However, the
comparison with the CG has shown a significant difference
because the latter had a clear worsening; this might indicate
that cognitive activation, even if was not able to improve
the IQ, at least was able to maintain it at the pre-activation
level; this was not true for the CG in which no activation was
carried out.
Statistically significant results were obtained in Ideomotor
praxis for all patients with M-NCD; this cognitive function has
not usually been taken into account in the literature, despite the
important role of motor components in the basic or instrumental
daily living activities. Also for constructional praxis we found
improved performance in the whole sample with M-NCD and in
the sub-groupwith AD.Onlymarginal significance was found for
changes in selective attention in the whole sample with M-NCD
only; we believe that this result might be explained by the low
power of our analysis due to its small sample size (a frequent
methodological problem in rehabilitation studies) and this holds
true for all the analyses we carried out.
In line with the results reported by the majority of studies in
the literature (Alves et al., 2013; Choi and Twamley, 2013), no
improvements in memory were found in our study, except for
visual memory (Enhanced Cued Recall), in which a statistically
significant result was obtained both for M-NCD as a whole (but
with a small effect size) and M-NCD due to AD. This result is
likely to be due to test administration and scoring, including
induction of semantic processing, immediate cued recall four-by-
four items, delayed free recall and delayed cued recall of all items;
total scores included both free and cued recall (Grober et al.,
1988), whereas, in the other memory tests, scores commonly
include free recall only. As a whole, memory functions was
very little improved; this result has an explanation in the early
and severe memory deterioration in M-NCD, especially due
to AD. The same applies for executive functions, in which no
improvement was found. Nevertheless, the comparison between
M-NCD and CG showed a statistically significant difference
both in immediate verbal recall and in frontal functions: this
result suggests that although g-ICA treatment did not cause
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TABLE 4 | Results obtained from the comparison between M-NCD (n = 16)
and CG (n = 11; Mann Whitney U test).
M-NCD CG M-NCD
∆ means (±SD) ∆ means (±SD) vs. CG
p
Global cognitive function
MODA 7.07 (4.9) 3.89 (4) <0.001
MMSE 3.25 (3.24) −2 (2.61) <0.001
Reasoning and cognitive level
Colored progressive
matrices 3.81 (6.72) −2.36 (1.91) 0.004
Memory
Digit span −0.31 (0.95) −0.27 (0.47) ns
Corsi’s test −0.06 (0.85) −0.09 (0.3) ns
Serial repetition of
two-syllabic words 0.19 (0.54) 0 (0) ns
Rey’s 15 words-
immediate recall 0.13 (5.78) −3.91 (2.91) 0.016
Rey’s 15 words-
delayed recall 0.31 (2.6) −0.36 (0.92) ns
Rey’s complex figure-
memory reproduction 1.22 (6.40) −0.55 (1.97) ns
Enhanced cued recall 1.00 (1.79) −1.00 (1.1) <0.001
Selective attention
Digit cancellation test 3.93 (8.46) −2.18 (3.76) 0.008
Praxis
Imitating gestures
test 8.17 (8.01) −5.59 (3.85) <0.001
Rey’s complex
figure-copy 5.11 (6.43) −1.91 (3.14) 0.005
Frontal functions
Frontal assessment
battery 1.20 (2.70) −0.91 (1.04) 0.015
Language
Aachener aphasia test
(AAT)—Token test 2.38 (2.96) −1.64 (2.54) 0.001
AAT—Repetition 1.75 (2.11) −1.18 (0.98) <0.001
AAT—Written language 1.56 (3.14) −0.64 (0.81) 0.014
AAT—Naming 3.88 (5.67) −1.09 (0.70) 0.002
AAT—Comprehension 2.06 (6.88) −0.73 (2.53) ns
improvements in these domains, it could be effective in slowing
down their worsening.
Regarding language abilities, comprehension and repetition
appeared to have improved in the whole sample, but effect
sizes were small; this result in persons with M-NCD is very
important, given the relevant role of language in communication
and in mediating interpersonal relationships. The g-ICA, indeed,
in addition to specific language tasks, includes a massive and
continuous exposure to verbal language, since it is the principal
vehicle of relationships between the patients and between
patients and the mediator. To date, there is no study in the
literature showing specific benefits of cognitive interventions on
verbal language. Also in this case, the comparison with the CG
group was able to disclose a slowing of the expected worsening of
these functions.
Regarding m-NCD, to the best of our knowledge, our study
is the only one in which an integrated cognitive approach has
been applied. The review by Wang et al. (2014) has confirmed
that cognition–based intervention (namely CT, CS, or memory
training) can be effective on global cognitive functioning and less
evidently, executive functions and delayed memory in patients
with MCI; we also found improved global cognitive function and
reasoning abilities (CPM scores). MMSE did not change but this
battery is probably not appropriate for detecting a mild cognitive
decline; in fact, all the patients in this group showed scores higher
than 24 at the pre-treatment assessment.
Also in m-NCD, memory domains, especially verbal memory,
were very little modified and some benefits were observed only in
verbal span (serial repetition of two-syllable words) and delayed
visual-spatial memory. In summary, the benefits obtained from
g-ICA treatment on global cognitive and frontal functions in
individuals with m-NCD confirm those reported earlier in the
literature; however, we detected additional benefits on praxis
ability, attention and verbal language.
This study has limitations and strengths. One limitation is the
absence of a CG for m-NCD patients. A second limitation is the
relatively small sample size of our groups, already cited above.
Another limitation of this study is that a specific relation between
one strategy and its effects cannot be established with certainty
because the g-ICA is a package of combined strategies; a cross-
over design (treating EG patients with all of the three techniques)
would have been appropriate and would have probably provided
more detailed data, but it was not possible to implement it
because of a series of practical and regulatory limitations that
do not allow us to follow patients intensively for a period
of time long enough. Another important limitation of this
program is the absence of labs specifically equipped for daily
living activities, which directly address one’s own self-efficacy
perception and therefore are fundamental, especially for persons
with M-NCD. g-ICA includes procedures aimed to facilitate not
only success in cognitive tasks, but also the general well-being of
patients, but in this first study, which had the main objective to
evaluate the cognitive effects of treatment, no measures of self-
esteem, quality of life and self-awareness were used. Finally, this
study had a baseline-treatment design that cannot allow strong
conclusions on the direct cause of the effects detected, because
of the impossibility to exclude competing hypotheses. However,
our results are promising and indicate the need to carry out
longer follow-up protocols in which an adequate CG can be
included.
Despite the limitations, mediation pedagogy and the errorless
learning can be considered to be important strengths of
this study because they facilitate enhancement of motivation
and removal of personal psychological barriers to cognitive
treatment. Moreover, the rich neuropsychological battery has
enabled the assessment of all the main cognitive functions,
offering the opportunity to add useful information to the data
already present in the literature. Since g-ICA is an intensive
treatment, it allows patients to activate themselves cognitively
for several hours, 5 days a week; on the contrary, previous
studies in the literature usually describe treatments lasting for
45–50 min, delivered 4 days a week at most (Spector et al.,
2003; Cipriani et al., 2006; Raggi et al., 2007; Talassi et al.,
2007; Yamagami et al., 2012). The intensity of such a treatment
was, most likely, another determining factor for the positive
results obtained. The g-ICA turned out to be effective and well
accepted by patients younger than 70–80 years, whereas studies
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in the literature have often reported results in older patients
(Spector et al., 2003; Cipriani et al., 2006; Yamagami et al., 2012;
Aguirre et al., 2013). Our treatment can be easily implemented
in a hospital setting, it is cost-effective and represents an
enrichment of the routine rehabilitation programs, as defined
by the local regulations (Italian Government Essential Assistance
Levels).
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